• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ARVN

ARVN

Arvinas, Inc.

NASDAQHealthcareBiotechnologyUS

USD7.70

-0.30 (-3.75%)

Rating:C

Company Profile

CEO

Randy Teel

IPO Date

2018-09-27

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$7.88

Prev. Close

$8.00

Day Low

$7.56

Day High

$7.94

52W Low

$6.06

52W High

$14.51

Market Cap

$0.50B

Volume

1.23M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

56.5%

Avg Negative

5.4%

Avg Neutral

38.0%

News Feed

Arvinas Inc Ranked Among Today's Top Shorts Amid Pandemic-Era Low Jobless Claims

Forbes·8/20/2021·↓ negative

Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas

PRNewsWire·8/9/2021·↑ positive

Analysts Estimate Arvinas, Inc. (ARVN) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research·7/27/2021·↑ positive

Arvinas, Inc. (ARVN) Moves 13% Higher: Will This Strength Last?

Zacks Investment Research·7/26/2021·↑ positive

Why Arvinas Jumped 10% Today

The Motley Fool·7/22/2021·↑ positive

ARVN Stock Increased Over 16% Intraday: Why It Happened

Pulse2·7/22/2021·↑ positive

Arvinas Participates in Groundbreaking Ceremony for New Space Within Downtown Crossing Development in New Haven

GlobeNewsWire·6/7/2021·↑ positive

Arvinas to Present at the UBS Global Healthcare Virtual Conference

GlobeNewsWire·5/20/2021·↑ positive

Arvinas Among Top Shorts Today As Dow, S&P 500, And Nasdaq Climb For Another Consecutive Day

Forbes·5/14/2021·↑ positive

Arvinas Signs Lease for New Space Within Downtown Crossing Development in New Haven

GlobeNewsWire·5/4/2021·↑ positive